Head and Neck Forum - Free Communications 2

8:15 AM • HN 05-01 • Sex differences in HPV immunity among adults without cancer > M. Melina Windon 8:25 AM • HN 05-02 • The use of HPV16-E5, EGFR and pEGFR as prognostic biomarkers for oropharyngeal cancer patients > M. Miren Taberna 8:35 AM • HN 05-03 • A p16 oral rinse test to enhance detection of oropharyngeal cancer > E. Elizabeth Franzmann 8:45 AM • HN 05-04 • Feasibility pilot study of a HPV16/18 E6 oncoprotein test in oropharyngeal and unknown primary cancers > E. Elisa Dal Cin 8:55 AM • HN 05-05 • Survival rates for patients with barrett high-grade dysplasia and esophageal adenocarcinoma with or without human papillomavirus infection > S. Shan Rajendra 9:05 AM • HN 05-06 • Effect of comorbidities on survival in HPV-related and -unrelated head and neck cancer survivors > D. Danielle Eytan 9:15 AM • HN 05-07 • Role of viral traits in prognosis of HPV16-related oropharyngeal cancer patients > L. Laia ALEMANY 9:25 AM • HN 05-08 • Minimally invasive dual testing for active HPV E6/E7 and PD-L1 expression in oropharyngeal cancer > H. Haitham MIRGHANI 9:35 AM • HN 05-09 • HPV in benign and malignant head and neck pathology > P. Pedro Valente